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OBJECTIVE — To validate the performance of current diabetes risk scores (DRSs) based on
simple clinical information in detecting type 2 diabetes, metabolic syndrome (MetSyn), and
chronic kidney disease (CKD).
RESEARCH DESIGN AND METHODS — The performance of 10 DRSs was evaluated
in a cross-sectional population screening of 2,759 Taiwanese subjects.
RESULTS — All DRSs signiﬁcantly correlated with measures of insulin resistance, estimated
glomerular ﬁltration rate, and urine albumin excretion. The prevalence of screening-detected
diabetes (SDM), MetSyn, and CKD increased with higher DRSs. For prediction of SDM, the
Cambridge DRS by Grifﬁn et al. and the Finnish DRS outperformed other DRSs in terms of
discriminativepowerandmodelﬁt.ForpredictionofMetSynandCKD,theAtherosclerosisRisk
in Community Study score by Schmidt et al. outperformed other DRSs.
CONCLUSIONS — Risk scores based on simple clinical information are useful to identify
individuals at high risk for diabetes, MetSyn, and CKD in different ethnic populations.
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T
he use of fasting or postchallenge
plasma glucose concentrations has
been proposed for the early identiﬁ-
cation of type 2 diabetes. However, both
tests are costly and time-consuming.
Therefore, a simple diabetes risk score
(DRS) that does not require any labora-
tory test is needed to identify individuals
at high risk. This study aimed to system-
atically evaluate the performance of cur-
rent DRSs based on simple clinical
information in identifying diabetes in a
cross-sectional population screening in
Taiwanese. The feasibility of these scores
in identifying individuals at high risk for
metabolic syndrome (MetSyn) and
chronic kidney disease (CKD), two con-
ditions closely related to type 2 diabetes,
were also evaluated.
RESEARCH DESIGN AND
METHODS
From 8 June 2005 to 22 November 2008,
2,759participantsundergoingcommunity-
based screening for type 2 diabetes in the
Yun-Lin area in Taiwan were recruited.
The exclusion criteria were age 18
years, pregnant women, previously diag-
nosed diabetes, or previously diagnosed
renal disease. Measures of insulin resis-
tance and -cell function were deter-
mined using the homeostasis model
assessment (HOMA)-2 with the use of a
HOMA calculator (www.dtu.ox.ac.uk).
The glomerular ﬁltration rate (GFR) was
estimated by the Modiﬁcation of Diet in
Renal Disease (MDRD) Study equation
(1). Urine albumin excretion was calcu-
lated using a random urine albumin-to-
creatinine ratio. Type 2 diabetes was
diagnosed by a fasting plasma glucose
concentration 126 mg/dl. MetSyn was
deﬁnedaccordingtotheNationalCholes-
terol Education Program Third Adult
TreatmentPanelguidelinewithmodiﬁca-
tion for Asian populations (2). CKD was
deﬁned as MDRD GFR 60 ml/min per
1.73m
2(1).ThecutoffvaluesforBMI(24
and 27 kg/m
2) and waist circumference
(90cmformen;80cmforwomen)were
modiﬁed according to the deﬁnition of
obesity for Taiwanese and the modiﬁed
waist circumference criteria for Asians
(2). Ten currently available DRSs, in-
cluding the Atherosclerosis Risk in
Community (ARIC) Study, Asian Indian,
Cambridge (U.K.), Danish, DESIR (Data
from the Epidemiological Study on Insu-
lin Resistance Syndrome) (French),
Dutch, FINDRISC (Finnish diabetes risk
score), Oman, QDScore (U.K.), and Thai
riskscores,wereanalyzed(3–12).Thein-
stitutional review board approved this
study, and informed consent was ob-
tainedfromeachparticipant.Theareaun-
der the receiver operating characteristic
(ROC) curves was used to assess the dis-
criminative power of DRSs. Model ﬁtness
was assessed by the Hosmer-Lemeshow
test, and the DeLong method was used to
compare areas under the ROC curves.
RESULTS
All DRSs correlated signiﬁcantly with com-
ponents of MetSyn, HOMA2–insulin resis-
tance, high-sensitive C-reactive protein,
anduricacidlevels,allofwhichweremark-
ersofinsulinresistance(supplementaryTa-
ble S1, found in an online appendix at
http://care.diabetesjournals.org/cgi/content/
full/dc09-0694/DC1). However, HOMA2-,
a measure of insulin secretion, did not
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tary Table S1). All DRSs were associated
with reduced MDRD GFR and with in-
creased urine albumin excretion (supple-
mentary Table S1). The prevalence of
screening-detected diabetes (SDM), MetSyn,
and CKD increased signiﬁcantly with in-
creasing DRSs (all P for trend 0.0001,
supplementary Figs. S1–S3).
Thepredictiveperformanceof10DRSs
for SDM, MetSyn, and CKD are summa-
rized in Table 1. The best area under the
ROC for SDM was 0.74 (95% CI 0.70–
0.77, Table 1), with 68% sensitivity and
70% speciﬁcity using optimal cutoff values.
There were no statistical differences in the
areaundertheROCforSDMamong ARIC,
QDScore, Cambridge, FINDRISC,
Oman, Danish, and Thai scores. How-
ever, the Cambridge risk score and the
FINDRISC outperformed the other DRSs
in model ﬁt. Using stepwise logistic re-
gression, we identiﬁed age, waist circum-
ference,medicationforhypertension,and
family history of diabetes as independent
predictors for SDM. The area under ROC
of the logistic regression model based on
these predictors was 0.75 (95% CI 0.71–
0.78) for SDM, similar to those of DRSs.
The best area under the ROC for
MetSynwas0.82(95%CI0.81–0.84,Ta-
ble1)with70%sensitivityand83%spec-
iﬁcity. There were no statistical
differences in the areas under the ROC
among the DESIR, Thai, and ARIC scores
forMetSyn.However,theARICscoreout-
performed other DRSs in model ﬁt.
The best area under the ROC curves
for CKD was 0.71 (95% CI 0.68–0.73)
(supplementary Fig. S2). The sensitivity
was 64% and speciﬁcity 68% to detect
CKD. The ARIC score outperformed
otherDRSsindiscriminativeperformance
for CKD and model ﬁt.
CONCLUSIONS
Thisstudyvalidatedthepredictiveperfor-
mance of currently available DRSs based
on simple clinical information for type 2
diabetes in a cross-sectional screening
program in Taiwan. The predictive per-
formanceoftheseDRSsamongTaiwanese
was comparable to those in other Euro-
pean populations (13). These data indi-
cate that DRSs based on simple clinical
information without laboratory test are
Table 1—The predictive performance of 10 diabetes risk scores for screening-detected diabetes, metabolic syndrome, and CKD
Model ROC area (95% CI) H-L P value Sensitivity Speciﬁcity
Correctly
classiﬁed LR
 LR

Youden
index
Number of
predictors
Screening-detected
diabetes
ARIC (U.S.) 0.74 (0.70–0.77) 0.01 0.68 0.70 0.69 2.23 0.46 0.39 6
QDScore (U.K.) 0.74 (0.70–0.77) 0.0001 0.73 0.63 0.64 1.99 0.42 0.38 9
Cambridge (U.K.) 0.73 (0.69–0.76) 0.23 0.64 0.67 0.67 1.95 0.54 0.31 7
FINDRISC (Finnish) 0.73 (0.69–0.77) 0.78 0.67 0.67 0.67 2.01 0.49 0.34 8
Oman 0.72 (0.69–0.75) 0.08 0.65 0.67 0.67 1.99 0.52 0.32 5
Danish 0.72 (0.68–0.76) 0.07 0.63 0.70 0.69 2.08 0.58 0.33 6
Thai 0.71 (0.67–0.74) 0.04 0.71 0.62 0.62 1.87 0.47 0.33 6
Asian Indian 0.70 (0.66–0.74) 0.0005 0.63 0.69 0.68 2.01 0.54 0.32 5
Dutch 0.69 (0.64–0.73) 0.016 0.61 0.70 0.70 2.03 0.56 0.31 4
DESIR (French) 0.67 (0.64–0.71) 0.009 0.55 0.70 0.69 1.82 0.64 0.28 4
Metabolic syndrome
DESIR (French) 0.82 (0.81–0.84) 0.002 0.70 0.83 0.79 4.06 0.37 0.53 4
Thai 0.82 (0.81–0.84) 0.0001 0.77 0.75 0.75 3.03 0.30 0.52 6
ARIC (U.S.) 0.81 (0.79–0.83) 0.62 0.74 0.73 0.73 2.72 0.35 0.47 6
Cambridge (U.K.) 0.80 (0.79–0.82) 0.0001 0.77 0.69 0.71 2.48 0.33 0.47 7
Asian Indian 0.78 (0.76–0.80) 0.0001 0.71 0.73 0.72 2.66 0.40 0.45 5
FINDRISC (Finnish) 0.77 (0.75–0.79) 0.0001 0.71 0.67 0.68 2.12 0.43 0.40 8
QDScore (U.K.) 0.77 (0.75–0.79) 0.0001 0.73 0.68 0.69 2.26 0.39 0.41 9
Danish 0.77 (0.76–0.79) 0.002 0.79 0.62 0.66 2.08 0.37 0.41 6
Dutch 0.73 (0.71–0.75) 0.0001 0.57 0.77 0.71 2.46 0.55 0.33 4
Oman 0.73 (0.71–0.74) 0.0001 0.76 0.62 0.66 2.02 0.39 0.41 5
CKD
ARIC (U.S.) 0.71 (0.68–0.73) 0.46 0.64 0.68 0.67 1.97 0.53 0.31 6
Cambridge (U.K.) 0.68 (0.66–0.70) 0.002 0.69 0.55 0.58 1.54 0.56 0.25 7
QDScore (U.K.) 0.68 (0.65–0.70) 0.0001 0.64 0.61 0.61 1.64 0.59 0.28 9
Danish 0.67 (0.65–0.69) 0.0001 0.62 0.63 0.63 1.63 0.63 0.27 6
Dutch 0.66 (0.64–0.69) 0.0001 0.59 0.74 0.72 2.27 0.55 0.33 4
Oman 0.66 (0.64–0.69) 0.0001 0.58 0.65 0.63 1.64 0.65 0.22 5
Asian Indian 0.65 (0.62–0.67) 0.0001 0.63 0.59 0.60 1.53 0.63 0.24 5
FINDRISC (Finnish) 0.62 (0.59–0.64) 0.006 0.68 0.49 0.52 1.32 0.66 0.17 8
Thai 0.61 (0.58–0.63) 0.0001 0.56 0.59 0.59 1.38 0.74 0.16 6
DESIR (French) 0.60 (0.58–0.63) 0.01 0.77 0.40 0.47 1.28 0.58 0.17 4
The optimal cutoff value was deﬁned as the one with the least (1  sensitivity)
2  (1  speciﬁcity)
2. Youden index was deﬁned as the maximum of (sensitivity 
speciﬁcity  1). H-L, Hosmer-Lemeshow goodness-of-ﬁt test; LR
, positive likelihood ratio; LR
, negative likelihood ratio.
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ing across different ethnic populations.
All DRSs strongly correlate with markers
of insulin resistance and are strong pre-
dictors for MetSyn. Therefore, DRSs are
actually predictors of insulin resistance,
which in turn predicts type 2 diabetes.
Another key ﬁnding of this study was
that all DRSs correlated with GFR and
urine albumin excretion and are fair pre-
dictors of CKD. Although a great deal of
effort has been exerted to develop a renal
risk score to identify individuals at high
risk of CKD, there is currently no simple
and widely established renal risk score
(14). Most proposed scoring models use
serum creatinine and urine protein as
themainpredictors,whichareoftennot
available in large-scale population
screening (14). Although the predictive
performance of DRSs cannot surpass
current renal risk models, the results
here demonstrate the potential feasibil-
ity of developing a simple renal risk
score to select high-risk individuals for
further laboratory screening.
This study has some limitations.
First, an oral glucose tolerance test was
not performed and 2-h glucose concen-
tration was not included in the deﬁni-
tion of diabetes. Second, other DRSs
including the American Diabetes Asso-
ciation risk tool, the Second National
Health and Nutrition Survey question-
naire by Herman et al., the German risk
scorebyShulzeetal.,andthenewARIC
risk scores by Kahn et al. were not in-
cluded in the analyses because of the
lack of delivery history, gestational dia-
betes history, detailed dietary informa-
tion, and ethnic-speciﬁc cutoff values
for weight and height (1517).
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